University Hospital, Mahdia   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Mahdia Tunisia

Organization Overview

First Clinical Trial
2014
NCT03580187
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

University Hospital, Mahdia

Active Ingredients

Drugs in Phase 4 Trials (2)

ketamine (ketalar) (1 trial)

ondansetron (zofran) (1 trial)

Drugs in Phase 3 Trials (1)

morphine (1 trial)

Drugs in Other Trials (1)

Bismuth Subcitrate Potassium (Pylera) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Wounds, Nonpenetrating (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4